JP2024544565A5 - - Google Patents

Info

Publication number
JP2024544565A5
JP2024544565A5 JP2024528591A JP2024528591A JP2024544565A5 JP 2024544565 A5 JP2024544565 A5 JP 2024544565A5 JP 2024528591 A JP2024528591 A JP 2024528591A JP 2024528591 A JP2024528591 A JP 2024528591A JP 2024544565 A5 JP2024544565 A5 JP 2024544565A5
Authority
JP
Japan
Prior art keywords
protein
igg
immunotherapy
cysteine protease
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024528591A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024544565A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/081841 external-priority patent/WO2023084095A2/en
Publication of JP2024544565A publication Critical patent/JP2024544565A/ja
Publication of JP2024544565A5 publication Critical patent/JP2024544565A5/ja
Pending legal-status Critical Current

Links

JP2024528591A 2021-11-15 2022-11-14 養子細胞移入免疫療法を増強する方法 Pending JP2024544565A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163279398P 2021-11-15 2021-11-15
US63/279,398 2021-11-15
PCT/EP2022/081841 WO2023084095A2 (en) 2021-11-15 2022-11-14 Methods for enhancing adoptive cell transfer immunotherapies

Publications (2)

Publication Number Publication Date
JP2024544565A JP2024544565A (ja) 2024-12-03
JP2024544565A5 true JP2024544565A5 (https=) 2025-11-25

Family

ID=84463039

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024528591A Pending JP2024544565A (ja) 2021-11-15 2022-11-14 養子細胞移入免疫療法を増強する方法

Country Status (7)

Country Link
US (1) US20250325640A1 (https=)
EP (1) EP4433587A2 (https=)
JP (1) JP2024544565A (https=)
CN (1) CN119013396A (https=)
AU (1) AU2022385450A1 (https=)
CA (1) CA3237815A1 (https=)
WO (1) WO2023084095A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025014862A1 (en) * 2023-07-07 2025-01-16 Emory University Recombinant glycosidases, pharmaceutical compositions, and uses in managing autoimmune or inflammatory conditions
WO2025030053A1 (en) * 2023-08-01 2025-02-06 Insmed Incorporated Novel igg proteases and methods of use thereof
CN120334552B (zh) * 2025-06-12 2025-09-12 成都蓉生药业有限责任公司 一种人免疫球蛋白对非人种属细胞的adcp活性的检测试剂的组合、检测试剂盒及其检测方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201413240D0 (en) 2014-07-25 2014-09-10 Hansa Medical Ab Method
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
CN114450397A (zh) * 2019-08-01 2022-05-06 纪念斯隆-凯特琳癌症中心 用于改善免疫疗法的细胞及其用途
GB202007434D0 (en) * 2020-05-19 2020-07-01 Hansa Biopharma AB Methods

Similar Documents

Publication Publication Date Title
US10774151B2 (en) Anti-human 4-1BB antibodies and uses thereof
AU2019301070B2 (en) Fusion constructs and methods of using thereof
JP2024544565A5 (https=)
CN110382539B (zh) 用于cd16a定向的nk细胞结合的串联双抗体
CN105142668B (zh) 治疗性肽
US20220372142A1 (en) Multimeric antibodies with enhanced selectivity for cells with high target density
CN106029694A (zh) 治疗性肽
TW202221021A (zh) 改良之抗原結合受體
TW202305006A (zh) 與ｃｄ４７及ｐｄ—ｌ１特異性結合的雙特異性抗體
WO2022216887A1 (en) Novel anti-cd4 antibodies
CN121399158A (zh) 用于治疗多发性骨髓瘤的方法
CN118176217A (zh) 新型抗体-细胞因子融合蛋白及其制备方法和用途
US20250325665A1 (en) Fusion constructs and methods of using thereof
JP2026501506A (ja) Ｃｌｄｎ１８．２及びｃｄ３に結合する二重特異性結合剤並びに免疫チェックポイント阻害剤を含む併用療法
WO2023093744A1 (zh) 一种双特异性抗原结合蛋白
CN119798438B (zh) 一种抗ccr8单克隆抗体及其应用
CN121889422A (zh) 能够结合干扰素γ的抗原结合分子
JP2026510493A (ja) 多機能抗体
JP2025531057A (ja) 疲弊した免疫細胞をレスキューする方法
KR20230124910A (ko) 염증성 피부 상태 치료 방법
HK40112413A (zh) 与PD-L1、CD137和/或TGFβ的双特异性和三特异性结合蛋白及其用途